Informations générales (source: ClinicalTrials.gov)
Determinants of Body Composition at Discharge and Fat-Free Mass as an Indicator of Neurological Development at 2 Years in Very Preterm Infants : OPTIPREMA Study (OPTIPREMA)
Observational
Hôpital de la Croix-Rousse (Voir sur ClinicalTrials)
avril 2014
décembre 2019
29 juin 2024
This study evaluates the perinatal factors influencing body composition at discharge in
very preterm infants and the relationship between fat free mass and further
neurocognitive development.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Hopital de la croix rousse - 69004 - Lyon - France | jean-charles picaud, MD, PhD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Preterm newborns (less or equal to 32 weeks gestation and / or birthweight less or
equal to1500g).
- Admitted in the Neonatal unit before day-of-life 7, staying at least 15 days in the
unit, and discharged home at ≥ 35 weeks postconceptional age directly from the
neonatal unit (no transfer)
- Oral Parental consent
- Preterm newborns (less or equal to 32 weeks gestation and / or birthweight less or
equal to1500g).
- Admitted in the Neonatal unit before day-of-life 7, staying at least 15 days in the
unit, and discharged home at ≥ 35 weeks postconceptional age directly from the
neonatal unit (no transfer)
- Oral Parental consent
- Hemodynamic or cardiovascular instability requiring continuous monitoring or
perfusion, incompatible with pediatric air-displacement plethysmography
- Pathology inducing neurodevelopment troubles
- Transfer in an other hospital before discharge
- Hemodynamic or cardiovascular instability requiring continuous monitoring or
perfusion, incompatible with pediatric air-displacement plethysmography